Literature DB >> 6812125

Isoprenaline increases brain concentrations of administered L-dopa and L-tryptophan in the rat.

T Eriksson, A Carlsson.   

Abstract

A small dose of isoprenaline or saline was administered intraperitoneally to rats 20 min before the administration of one of the amino acids L-dopa or L-tryptophan. Isoprenaline caused a marked increase in the brain concentration of the administered amino acid. Isoprenaline has previously been shown to cause a decrease in at least some of those plasma amino acids which compete with L-dopa and tryptophan for carrier-mediated transport into the brain. The effect of isoprenaline on the concentrations of dopa and tryptophan in the brain is suggested to be at least partly caused by a change in the relationship between endogenous and administered amino acids. It is also possible that a direct effect of isoprenaline on the blood-brain barrier transport system contributes to the effect. The reported finding might be of clinical interest in view of the therapeutic importance of aromatic amino acids with a central site of action.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812125     DOI: 10.1007/bf00436106

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

Review 1.  Control of brain neurotransmitter synthesis by precursor availability and nutritional state.

Authors:  R J Wurtman; J D Fernstrom
Journal:  Biochem Pharmacol       Date:  1976-08-01       Impact factor: 5.858

2.  A fluorometric method for the estimation of tyrosine in plasma and tissues.

Authors:  T P WAALKES; S UDENFRIEND
Journal:  J Lab Clin Med       Date:  1957-11

3.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

4.  Brain serotonin content: physiological regulation by plasma neutral amino acids.

Authors:  J D Fernstrom; R J Wurtman
Journal:  Science       Date:  1972-10-27       Impact factor: 47.728

5.  A procedure for the isolation of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from the same tissue sample using a single column of strongly acidic cation exchange resin.

Authors:  C Atack; T Magnusson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-01

6.  Effects of hypophysectomy, adrenalectomy and (-)-propranolol on ethanol-induced decrease in plasma amino acids.

Authors:  T Eriksson; T Magnusson; A Carlsson; M Hagman; R Jagenburg; S Edén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-11       Impact factor: 3.000

7.  Effect of isoprenaline infusion on the distribution of tryptophan, tyrosine and isoleucine between brain and other tissues.

Authors:  P H Hutson; P J Knott; G Curzon
Journal:  Biochem Pharmacol       Date:  1980-02-15       Impact factor: 5.858

8.  A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain.

Authors:  W Kehr; A Carlsson; M Lindqvist
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

9.  Effects on plasma and brain tryptophan in the rat of drugs and hormones that influence the concentration of unesterified fatty acid in the plasma.

Authors:  G Curzon; P J Knott
Journal:  Br J Pharmacol       Date:  1974-02       Impact factor: 8.739

10.  A fluorimetric method for the determination of dopamine (3-hydroxytyramine).

Authors:  A CARLSSON; B WALDECK
Journal:  Acta Physiol Scand       Date:  1958-12-15
View more
  4 in total

1.  In vivo evidence for a greater brain tryptophan hydroxylase capacity in female than in male rats.

Authors:  M Carlsson; A Carlsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

2.  Effects of mild stress on adrenal and heart catecholamines in male and female rats.

Authors:  M Carlsson; A Carlsson
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

Review 3.  Drug interactions at the blood-brain barrier: fact or fantasy?

Authors:  Sara Eyal; Peng Hsiao; Jashvant D Unadkat
Journal:  Pharmacol Ther       Date:  2009-04-22       Impact factor: 13.400

4.  Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups.

Authors:  Yoshiyuki Soeda; Misato Yoshikawa; Osborne F X Almeida; Akio Sumioka; Sumihiro Maeda; Hiroyuki Osada; Yasumitsu Kondoh; Akiko Saito; Tomohiro Miyasaka; Tetsuya Kimura; Masaaki Suzuki; Hiroko Koyama; Yuji Yoshiike; Hachiro Sugimoto; Yasuo Ihara; Akihiko Takashima
Journal:  Nat Commun       Date:  2015-12-16       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.